The European Union and India are moving quickly toward implementing what would be the largest trade agreement either side has ever concluded. Negotiations on the EU-India Free Trade Agreement were completed in January 2026, and in September the European Commission formally submitted the agreement to the Council of the European...
India’s Chemical Sector Poised for Rapid Growth
The Indian chemicals sector stands out as one of the most rapidly advancing industries globally. India is the sixth-largest chemical producer, with a market size of $178 billion in 2021. Per industry reports, this sector is set for further expansion, with an anticipated growth rate of 12%, reaching a value...
Why is India the Future of Global Production of APIs?
Following a recent visit to three Indian cities, Frederic Kahn, head of Active Pharmaceutical Ingredients (API's) at Wavelength Pharmaceuticals by Seqens, posits six reasons why India is the future of global production of APIs. Lightly edited summary of Kahn's views: 1. India, a new intermediary in the pharmaceutical ecosystem "India...
Indian trade group allies with govt agencies for Med-Tech Investment
Medical Technology Association of India (MTaI) has been engaging with the Department of Pharmaceuticals and the Invest India Team closely to work on several corrective measures which will help bring FDI back on track and promote investments in the medical device sector.
Hospira gets into R&D and Manufacturing
Lake Forest, Illinois based Hospira acquired an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development facility in Aurangabad from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for $218 million. "Hospira's acquisition of the 665 employee Orchid API facility will support supply continuity of...